Jetpharma
Switzerland 60 employees 2 duplicate records merged Updated 9 July 2026
Jetpharma is a finished-dose manufacturer based in Switzerland. It appears in 21 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 23 June 2023 as NAI.
2
registered plants
1 with an FDA FEI number
21
filings
across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
6 of 6 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.
Inspection history
- 23 June 2023 NAI US FDA
- 7 February 2020 VAI US FDA
- 1 December 2017 VAI US FDA
- 29 January 2016 VAI US FDA
- 8 May 2013 NAI US FDA
- 16 February 2011 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Balerna, Switzerland | Not on file |
| Switzerland, Switzerland | 3002807359 |
What they file, and where
| Molecule | Regulators | Docs |
| Roflumilast | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| NPRA (MY) | 21 | None |
| US FDA | None | 1 |
| EMA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Jetpharma comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was NAI, on 23 June 2023.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates